| Literature DB >> 35528947 |
Mizue Suzuki1, Yuhei Otobe1, Takeo Ichikawa1, Shingo Koyama1, Shu Tanaka1, Yusuke Maetani1, Hiroaki Masuda1, Shuhei Shino1, Yosuke Kimura2, Minoru Yamada3.
Abstract
Objectives: This study examined the social factors affecting the frequency of going out, and social isolation related to the frequency of daily conversation, stratified by gender. Method: The participants comprised 1,016 community-dwelling older Japanese adults, who were categorized into four groups: those who are (1) not isolated socially and go out every day, (2) not isolated socially and do not go out every day, (3) socially isolated and go out every day, and (4) socially isolated and do not go out every day. We performed a logistic regression analysis to assess the relationship between the frequency of daily conversation and the four groups.Entities:
Keywords: Community-dwelling older adults; Frequency of daily conversation; Frequency of going out; Social isolation
Year: 2022 PMID: 35528947 PMCID: PMC9053121 DOI: 10.1007/s12126-022-09494-6
Source DB: PubMed Journal: Ageing Int ISSN: 0163-5158
Characteristics of men participants
| All | Group 1 | Group 2 | Group 3 | Group 4 | p | post-hoc | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n = 475 | n = 146 | n = 67 | n = 134 | n = 128 | ||||||||
| -100.00% | -30.70% | -14.10% | -28.20% | -26.90% | ||||||||
| Age (years), median [IQR] | 74 | [69.0 - 79.0] | 71.5 | [68.0 - 77.3] | 75 | [71.0 - 81.0] | 73 | [68.0 - 78.0] | 74.5 | [69.0 - 81.0] | 0.003 | 1, 3 |
| Height (cm), median [IQR] | 165 | [161.0 - 169.0] | 166 | [163.0 - 170.0] | 165 | [160.0 - 170.0] | 165.4 | [161.0 - 169.3] | 164 | [160.0 - 168.0] | 0.005 | 3 |
| Weight (kg), median [IQR] | 62 | [56.0 - 68.0] | 62.8 | [60.0 - 70.0] | 63 | [58.0 - 67.0] | 62.8 | [55.0 - 69.3] | 60 | [54.0 - 66.8] | 0.003 | 3 |
| BMI (kg/m2), median [IQR] | 22.9 | [21.2 - 24.5] | 22.9 | [21.6 - 24.5] | 23 | [21.4 - 24.8] | 23.1 | [21.1 - 24.8] | 22.4 | [19.9 - 24.2] | 0.136 | |
| Number of comorbidities, median [IQR] | 1 | [1 - 2] | 1 | [1 - 2] | 1 | [1 - 2] | 1 | [1 - 2] | 1 | [0 - 2] | 0.494 | |
| Heart disease, n (%) | 82 | -17.3 | 22 | -15.1 | 12 | -17.9 | 27 | -20.1 | 21 | -16.4 | 0.882 | |
| Hypertension, n (%) | 216 | -45.5 | 73 | -50 | 33 | -49.3 | 56 | -41.8 | 54 | -42.2 | 0.329 | |
| Stroke, n (%) | 18 | -3.8 | 6 | -4.1 | 4 | -6 | 4 | -3 | 4 | -3.1 | 0.885 | |
| Dyslipidemia, n (%) | 32 | -6.7 | 11 | -7.5 | 3 | -4.5 | 9 | -6.7 | 9 | -7 | 0.765 | |
| Diabetes mellitus, n (%) | 74 | -15.6 | 22 | -15.1 | 8 | -11.9 | 25 | -18.7 | 19 | -14.8 | 0.701 | |
| Musculoskeletal disorders, n (%) | 96 | -20.2 | 20 | -13.7 | 17 | -25.4 | 30 | -22.4 | 29 | -22.7 | 0.062 | |
| Pulmonary disease, n (%) | 23 | -4.8 | 5 | -3.4 | 4 | -6 | 5 | -3.7 | 9 | -7 | 0.126 | |
| Malignant tumor, n (%) | 41 | -8.6 | 6 | -4.1 | 6 | -9 | 14 | -10.4 | 15 | -11.7 | 0.041 | n.s. |
| Polypharmacy, n (%) | 109 | -22.9 | 34 | -23.3 | 16 | -23.9 | 28 | -20.9 | 31 | -24.2 | 0.754 | |
| Living alone, n (%) | 35 | -7.4 | 5 | -3.4 | 4 | -6 | 11 | -8.2 | 15 | -11.7 | 0.017 | n.s. |
| LSNS-6 (points), median [IQR] | 11 | [6 - 15] | 15 | [13 - 15] | 15 | [13 - 15] | 7 | [5 - 9] | 6 | [3 - 9] | < 0.001 | 2, 3, 4, 5 |
| SPPB (points), median[IQR] | 12 | [12 - 12] | 12 | [12 - 12] | 12 | [11 - 12] | 12 | [12 - 12] | 12 | [12 - 12] | 0.139 | |
| ≤ 9 points, n (%) | 25 | -5.3 | 4 | -2.7 | 5 | -7.5 | 7 | -5.2 | 9 | -7 | 0.091 | |
| MMSE (points), median[IQR] | 29 | [26 - 30] | 29 | [27 - 30] | 28 | [27 - 30] | 29 | [27 - 30] | 28 | [25 - 30] | 0.001 | 3, 6 |
| ≤ 26 points, n (%) | 126 | -26.5 | 33 | -22.6 | 15 | -11.9 | 29 | -21.6 | 49 | -38.3 | 0.004 | 3, 6 |
| Depression, n(%) | 141 | -29.7 | 24 | -16.4 | 19 | -28.4 | 38 | -28.4 | 60 | -46.9 | < 0.001 | 3, 6 |
| Use of dentures, n (%) | 244 | -51.4 | 74 | -50.7 | 35 | -52.2 | 69 | -51.5 | 66 | -51.6 | 0.871 | |
| Maximum tongue pressure (kPa), median[IQR] | 32.1 | [26.4 - 37.7] | 33.1 | [27.0 - 39.4] | 30.1 | [23.4 - 34.6] | 32.5 | [27.6 - 37.7] | 31.5 | [25.1 - 37.2] | 0.064 | |
| Oral diadochokinesis 'pa' (times/s), median[IQR] | 6.2 | [5.4 - 6.8] | 6.4 | [5.8 - 6.8] | 5.8 | [5.4 - 6.4] | 6.2 | [5.6 - 6.8] | 6 | [5.2 - 6.6] | < 0.001 | 1, 3 |
| Oral diadochokinesis 'ta' (times/s), median[IQR] | 6 | [5.4 - 6.6] | 6.2 | [5.6 - 6.8] | 5.8 | [4.8 - 6.6] | 6 | [5.4 - 6.6] | 5.8 | [5.2 - 6.4] | 0.002 | 1, 3 |
| Oral diadochokinesis 'ka' (times/s), median[IQR] | 5.6 | [4.8 - 6.2] | 5.8 | [5.2 - 6.2] | 5.2 | [4.2 - 6.0] | 5.6 | [4.8 - 6.2] | 5.4 | [4.6 - 6.2] | 0.004 | 1, 3 |
| Peak cough flow (L/min), median[IQR] | 290 | [200 - 380] | 300 | [200 - 380] | 260 | [160 - 340] | 280 | [200 - 380] | 300 | [190 - 390] | 0.222 | |
| Maximum phonation time (sec), median[IQR] | 20.1 | [14.4 - 25.9] | 21.9 | [16.2 - 28.0] | 18.5 | [12.9 - 23.8] | 20.2 | [14.4 - 26.1] | 18.2 | [13.0 - 24.7] | 0.008 | 3 |
| Subjective daily conversation (less), n (%) | 191 | -40.2 | 31 | -21.2 | 27 | -40.3 | 61 | -45.5 | 72 | -56.3 | < 0.001 | 1, 2, 3 |
| Number of day they converse (daily), n (%) | 289 | -60.8 | 127 | -87 | 36 | -53.7 | 86 | -64.2 | 40 | -31.3 | < 0.001 | 1, 2, 3, 5, 6 |
| Number of conversation people (4 or more), n (%) | 278 | -58.5 | 118 | -80.8 | 42 | -62.7 | 73 | -54.5 | 45 | -35.2 | < 0.001 | 1, 2, 3, 5, 6 |
Group 1, not isolated socially and going out every day; Group 2, not isolated socially and not going out every day; Group 3, socially isolated and going out every day; Group 4, socially isolated and not going out every day. The number indicates a significant difference by the post hoc test: 1, Group1 vs Group2. 2, Group 1 vs Group 3. 3, Group 1 vs Group 4. 4, Group 2 vs Group 3. 5, Group 2 vs Group 4. 6, Group 3 vs Group 4
IQR Interquartile Range, n.s not significant, BMI Body Mass Index, LSNS-6 Lubben Social Network Scale-6, SPPB Short Physical Performance Battery, MMSE Mini-Mental State Examination
Characteristics of women participants
| All | Group 1 | Group 2 | Group 3 | Group 4 | p | post-hoc | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n = 541 | n = 160 | n = 122 | n = 107 | n = 152 | ||||||||
| -100.00% | -29.60% | -22.60% | -19.80% | -28.10% | ||||||||
| Age (years), median [IQR] | 73 | [69.0 - 77.0] | 71.5 | [69.0 - 77.0] | 73 | [70.0 - 78.0] | 72 | [67.0 - 76.0] | 74 | [70.0 - 78.0] | 0.008 | 6 |
| Height (cm), median [IQR] | 151.8 | [148.0 - 155.5] | 152 | [149.0 - 156.0] | 152 | [149.0 - 156.3] | 153 | [149.0 - 156.0] | 150 | [147.0 - 155.0] | 0.035 | n.s. |
| Weight (kg), median [IQR] | 51 | [46.5 - 56.0] | 52 | [46.6 - 56.8] | 51 | [46.4 - 56.0] | 50 | [47.0 - 55.0] | 50 | [46.0 - 56.0] | 0.582 | |
| BMI (kg/m2), median [IQR] | 22.1 | [20.4 - 24.0] | 22.2 | [20.6 - 24.1] | 21.9 | [20.1 - 23.5] | 21.7 | [20.2 - 23.9] | 22.4 | [20.5 - 24.0] | 0.368 | |
| Number of comorbidities, median [IQR] | 1 | [1 - 2] | 1 | [1 - 2] | 1 | [0 - 2] | 1 | [1 - 2] | 1 | [1 - 2] | 0.867 | |
| Heart disease, n (%) | 47 | -8.7 | 11 | -6.9 | 14 | -11.5 | 5 | -4.7 | 17 | -11.2 | 0.074 | |
| Hypertension, n (%) | 226 | -41.8 | 69 | -43.1 | 44 | -41.1 | 50 | -41 | 63 | -41.4 | 0.762 | |
| Stroke, n (%) | 10 | -1.8 | 2 | -1.3 | 3 | -2.5 | 3 | -2.8 | 2 | -1.3 | 0.982 | |
| Dyslipidemia, n (%) | 105 | -19.4 | 41 | -25.6 | 19 | -15.6 | 25 | -23.4 | 20 | -13.2 | 0.002 | 3 |
| Diabetes mellitus, n (%) | 34 | -6.3 | 12 | -7.5 | 10 | -8.2 | 5 | -4.7 | 7 | -4.6 | 0.481 | |
| Musculoskeletal disorders, n (%) | 202 | -37.3 | 50 | -31.3 | 39 | -32 | 42 | -39.3 | 71 | -46.7 | 0.018 | 3 |
| Pulmonary disease, n (%) | 19 | -3.5 | 5 | -3.1 | 3 | -2.5 | 5 | -4.7 | 6 | -3.9 | 0.897 | |
| Malignant tumor, n (%) | 35 | -6.5 | 13 | -8.1 | 9 | -7.4 | 5 | -4.7 | 8 | -5.3 | 0.443 | |
| Polypharmacy, n (%) | 93 | -17.2 | 27 | -16.9 | 20 | -16.4 | 15 | -14 | 31 | -20.4 | 0.373 | |
| Living alone, n (%) | 86 | -15.9 | 25 | -15.6 | 27 | -22.1 | 13 | -12.1 | 21 | -13.8 | 0.865 | |
| LSNS-6 (points), median [IQR] | 12 | [8 - 15] | 16 | [14 - 19] | 15 | [13 - 16] | 8 | [5 - 10] | 7 | [5 - 9] | < 0.001 | 2, 3, 4, 5 |
| SPPB (points), median[IQR] | 12 | [12 - 12] | 12 | [12 - 12] | 12 | [12 - 12] | 12 | [12 - 12] | 12 | [12 - 12] | 0.045 | n.s. |
| ≤ 9 points, n (%) | 17 | -3.1 | 4 | -2.5 | 3 | -2.5 | 2 | -1.9 | 8 | -5.3 | 0.167 | |
| MMSE (points), median[IQR] | 29 | [27 - 30] | 30 | [28 - 30] | 29 | [27 - 30] | 29 | [27 - 30] | 29 | [27 - 30] | 0.018 | 3 |
| ≤ 26 points, n (%) | 112 | -20.7 | 23 | -14.4 | 30 | -24.6 | 21 | -19.6 | 38 | -25 | 0.012 | n.s. |
| Depression, n(%) | 206 | -38.1 | 42 | -26.3 | 43 | -35.2 | 40 | -37.4 | 81 | -53.3 | < 0.001 | 3, 5 |
| Use of dentures, n (%) | 299 | -55.3 | 93 | -58.1 | 70 | -57.4 | 48 | -44.9 | 88 | -57.9 | 0.662 | |
| Maximum tongue pressure (kPa), median[IQR] | 30.5 | [25.6 - 35.7] | 32 | [25.7 - 36.9] | 29.9 | [25.1 - 35.2] | 31.7 | [27.0 - 36.5] | 29 | [23.7 - 33.9] | 0.008 | 3 |
| Oral diadochokinesis 'pa' (times/s), median[IQR] | 6.4 | [5.8 - 6.8] | 6.4 | [6.0 - 7.0] | 6.4 | [5.8 - 6.8] | 6.4 | [6.0 - 7.0] | 6.2 | [5.6 - 6.6] | 0.005 | 3, 6 |
| Oral diadochokinesis 'ta' (times/s), median[IQR] | 6.2 | [5.6 - 6.8] | 6.2 | [5.8 - 6.8] | 6.2 | [5.4 - 6.7] | 6.4 | [5.8 - 7.0] | 6 | [5.4 - 6.6] | 0.007 | 6 |
| Oral diadochokinesis 'ka' (times/s), median[IQR] | 6 | [5.4 - 6.4] | 6 | [5.6 - 6.4] | 5.8 | [5.2 - 6.4] | 6 | [5.6 - 6.6] | 5.8 | [5.2 - 6.2] | 0.001 | 3, 6 |
| Peak cough flow (L/min), median[IQR] | 200 | [150 - 250] | 190 | [140 - 250] | 190 | [140 - 250] | 220 | [170 - 270] | 200 | [150 - 250] | 0.061 | |
| Maximum phonation time (sec), median[IQR] | 17.6 | [13.3 - 22.2] | 18.7 | [14.3 - 23.8] | 17.2 | [13.9 - 22.4] | 16.6 | [12.9 - 21.9] | 17.4 | [12.1 - 21.4] | 0.062 | |
| Subjective daily conversation (less), n (%) | 127 | -23.5 | 20 | -12.5 | 22 | -18 | 29 | -27.1 | 56 | -36.8 | < 0.001 | 2, 3, 5 |
| Number of day they converse (daily), n (%) | 304 | -56.2 | 128 | -80 | 71 | -58.2 | 59 | -55.1 | 46 | -30.3 | < 0.001 | 1, 2, 3, 5, 6 |
| Number of conversation people (4 or more), n (%) | 359 | -66.4 | 137 | -85.6 | 87 | -71.3 | 66 | -61.7 | 69 | -45.4 | < 0.001 | 1, 2, 3, 5, 6 |
Group 1, not isolated socially and going out every day; Group 2, not isolated socially and not going out every day; Group 3, socially isolated and going out every day; Group 4, socially isolated and not going out every day vs Group 4. The number indicates a significant difference by the post hoc test: 1, Group1 vs Group2. 2, Group 1 vs Group 3. 3, Group 1 vs Group 4. 4, Group 2 vs Group 3. 5, Group 2 vs Group 4. 6, Group 3 vs Group 4
IQR Interquartile Range, n.s not significant, BMI Body Mass Index, LSNS-6 Lubben Social Network Scale-6, SPPB Short Physical Performance Battery, MMSE Mini-Mental State Examination
Fig. 1Comparison of subjective daily conversation and social factors between genders. A Lubben Social Network Scale-6. B Going out every day. C Frequency of subjective daily conversation
Fig. 2A Classification of participants according to the combination of social isolation and frequency of going out. Group 1, not isolated socially and going out every day. Group 2, not isolated socially and not going out every day. Group 3, socially isolated and going out every day. Group 4, socially isolated and not going out every day. B Proportion of subjective daily conversation for each group
Multivariable analysis for subjective daily conversation
| OR | 95% CI | p | OR | 95% CI | p | OR | 95% CI | p | OR | 95% CI | p | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Group 1 (n = 146) | 21.2% (n = 31) | ref | - | - | ref | - | - | ref | - | - | ref | - | - | ||
| Group 2 (n = 67) | 40.3% (n = 27) | 2.50 | 1.34—4.70 | 0.004 | 2.50 | 1.32—4.73 | 0.005 | 2.37 | 1.25—4.51 | 0.008 | 2.13 | 1.10—4.12 | 0.025 | ||
| Group 3 (n = 134) | 45.5% (n = 61) | 3.10 | 1.84—5.23 | < 0.001 | 3.01 | 1.78—5.10 | < 0.001 | 2.87 | 1.69—4.88 | < 0.001 | 2.92 | 1.70—5.00 | < 0.001 | ||
| Group 4 (n = 128) | 56.3% (n = 72) | 4.77 | 2.81—8.09 | < 0.001 | 4.62 | 2.70—7.91 | < 0.001 | 4.10 | 2.36—7.13 | < 0.001 | 4.28 | 2.43—7.54 | < 0.001 | ||
| OR | 95% CI | p | OR | 95% CI | p | OR | 95% CI | p | OR | 95% CI | p | ||||
| Group 1 (n = 160) | 12.5% (n = 20) | ref | - | - | ref | - | - | ref | - | - | ref | - | - | ||
| Group 2 (n = 122) | 18.0% ( n = 22) | 1.54 | 0.80—2.97 | 0.198 | 1.56 | 0.80—3.03 | 0.190 | 1.53 | 0.78—3.00 | 0.219 | 1.51 | 0.77—2.98 | 0.235 | ||
| Group 3 (n = 107) | 27.1% (n = 29) | 2.60 | 1.38—4.90 | 0.003 | 2.69 | 1.42—5.10 | 0.002 | 2.57 | 1.35—4.91 | 0.004 | 2.42 | 1.25—4.68 | 0.008 | ||
| Group 4 (n = 152) | 36.8% (n = 56) | 4.08 | 2.30—7.24 | < 0.001 | 4.32 | 2.41—7.73 | < 0.001 | 3.87 | 2.13—7.03 | < 0.001 | 3.81 | 2.08—7.00 | < 0.001 | ||
Group 1, not isolated socially and going out every day; Group 2, not isolated socially and not going out every day; Group 3, socially isolated and going out every day; Group 4, socially isolated and not going out every day. Model 1: crude, Model 2 : adjusted for age, BMI, number of comorbidities , polypharmacy, living alone, Model 3 : Model 2 + adjusted for SPPB, depression, MMSE, Model 4 : Model 3 + adjusted for use of dentures, maximum tongue pressure, oral diadochokinesis 'pa', 'ta', 'ka', peak cough flow, maximum phonation time
OR Odds Ratio, CI Confidence Interval